Stockreport

Third party verification of Aradigm's late-stage studies of inhalable ciprofloxacin completed; shares up 2% [Seeking Alpha]

ARADIGM CORP COMMON STOCK  (ARDM) 
US:NASDAQ Investor Relations: investor.aradigm.com
PDF Third party verification of Aradigm's late-stage studies of inhalable ciprofloxacin completed; shares up 2% [Read more]